Omega-3 Supplementation and Vitreal VEGF Levels in Wet-AMD
Not Applicable
Completed
- Conditions
- Exudative Age Related Macular Degeneration
- Interventions
- Dietary Supplement: Anti-VEGF plus AREDS-1Dietary Supplement: Anti-VEGF plus AREDS-2
- First Posted Date
- 2013-03-27
- Last Posted Date
- 2017-04-24
- Lead Sponsor
- Maisonneuve-Rosemont Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT01819415
- Locations
- 🇨🇦
Maisonneuve Rosemont Hospital, Montreal, Quebec, Canada
Survival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)
Completed
- Conditions
- Peritoneal Mesotheliomas
- Interventions
- Procedure: Cytoreductive surgery and HIPEC
- First Posted Date
- 2013-03-18
- Last Posted Date
- 2013-03-18
- Lead Sponsor
- Maisonneuve-Rosemont Hospital
- Target Recruit Count
- 19
- Registration Number
- NCT01812148
- Locations
- 🇨🇦
Maisonneuve Rosemont Hospital, Montréal, Quebec, Canada
Mismatched Donor Cells to Treat Acute Myeloid Leukemia
Phase 1
- Conditions
- Acute Myeloid Leukemia
- Interventions
- Biological: ATAC Therapy
- First Posted Date
- 2013-02-15
- Last Posted Date
- 2017-08-30
- Lead Sponsor
- Maisonneuve-Rosemont Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT01793025
- Locations
- 🇨🇦
Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada
Does Nightly Dexmedetomidine Improve Sleep and Reduce Delirium in ICU Patients?
- First Posted Date
- 2013-02-13
- Last Posted Date
- 2017-03-17
- Lead Sponsor
- Maisonneuve-Rosemont Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT01791296
- Locations
- 🇨🇦
Maisonneuve Rosemont Hospital, Montréal, Quebec, Canada
🇺🇸Tufts Medical Center, Boston, Massachusetts, United States
Single Pre-Operative Radiation Therapy (SPORT) for Low Risk Breast Cancer
Phase 1
Completed
- Conditions
- Breast Cancer
- Interventions
- Radiation: Single Pre-Operative Radiation Therapy
- First Posted Date
- 2012-10-30
- Last Posted Date
- 2023-11-01
- Lead Sponsor
- Maisonneuve-Rosemont Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT01717261
- Locations
- 🇨🇦
Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada
ED90 Determination of Carbetocin for the Prevention of Uterine Atony in Women Undergoing an Elective Cesarean Delivery
- First Posted Date
- 2012-04-17
- Last Posted Date
- 2013-02-15
- Lead Sponsor
- Maisonneuve-Rosemont Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT01579201
- Locations
- 🇨🇦
Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada
Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant
Phase 2
Terminated
- Conditions
- Respiratory Tract InfectionsBronchiolitis ObliteransCryptogenic Organizing PneumoniaLung Diseases, Interstitial
- Interventions
- First Posted Date
- 2011-09-12
- Last Posted Date
- 2021-10-20
- Lead Sponsor
- Maisonneuve-Rosemont Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT01432080
- Locations
- 🇨🇦
Maisonneuve-Rosemont Hospital (Hôpital Maisonneuve-Rosemont), Montreal, Quebec, Canada
ED50 Determination of Hydroxyethylstarch for Treatment of Hypotension During Cesarean Section Under Spinal Anesthesia
Phase 4
- Conditions
- Obstetric AnesthesiaSpinal AnesthesiaHypotensionFluid TherapyCesarean Section
- Interventions
- First Posted Date
- 2011-08-11
- Last Posted Date
- 2013-02-15
- Lead Sponsor
- Maisonneuve-Rosemont Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT01415284
- Locations
- 🇨🇦
Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada
Safety Evaluation of Dexmedetomidine for EBUS-TBNA
- First Posted Date
- 2011-06-27
- Last Posted Date
- 2013-02-28
- Lead Sponsor
- Maisonneuve-Rosemont Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT01381627
- Locations
- 🇨🇦
Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada
The Impact of Post-tetanic Count on Subsequent Train-of-four During Recovery From Rocuronium
Completed
- Conditions
- Post-tetanic Count on One Arm, the Other Arm is the Control
- Interventions
- Device: NMT (a device that can do neurostimulation and can record the response on the stimulation by Datex)
- First Posted Date
- 2010-03-12
- Last Posted Date
- 2010-04-27
- Lead Sponsor
- Maisonneuve-Rosemont Hospital
- Target Recruit Count
- 22
- Registration Number
- NCT01086176
- Locations
- 🇨🇦
Hopital Maisonneuve-Rosemont, Montréal, Quebec, Canada
© Copyright 2025. All Rights Reserved by MedPath